Comparative Pharmacology
Head-to-head clinical analysis: CLOBAZAM versus MIDAZOLAM HYDROCHLORIDE AUTOINJECTOR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLOBAZAM versus MIDAZOLAM HYDROCHLORIDE AUTOINJECTOR.
CLOBAZAM vs MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Clobazam is a benzodiazepine that enhances the effect of GABA at the GABA-A receptor, increasing chloride ion conductance and neuronal hyperpolarization. It has a high affinity for the α2 subunit, which may contribute to its anticonvulsant effects.
Midazolam is a short-acting benzodiazepine that potentiates GABA-A receptor activity by binding to the benzodiazepine site, enhancing chloride ion conductance and neuronal hyperpolarization, leading to anxiolytic, sedative, amnestic, anticonvulsant, and muscle relaxant effects.
10-60 mg orally once daily, divided into two doses. Typical starting dose: 10 mg twice daily.
10 mg intramuscularly once via autoinjector for acute seizure control.
None Documented
None Documented
Clinical Note
moderateClobazam + Estrone sulfate
"The serum concentration of Estrone sulfate can be decreased when it is combined with Clobazam."
Clinical Note
moderateClobazam + Fluticasone propionate
"The risk or severity of adverse effects can be increased when Clobazam is combined with Fluticasone propionate."
Clinical Note
moderateClobazam + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Clobazam."
Clinical Note
moderateClobazam + Erythromycin
Clobazam: 36–42 hours; N-desmethylclobazam: 71–82 hours. Steady state achieved in 5–10 days.
Terminal elimination half-life is 1.8–6.4 hours (mean ~3 hours) in healthy adults; prolonged in elderly, obese, hepatic impairment (up to 15–20 hours), and critical illness.
Renal: ~82% as metabolites (mainly N-desmethylclobazam and hydroxylated metabolites), unchanged clobazam <1%; fecal: ~11%.
Renal excretion of metabolites (glucuronide conjugates) accounts for approximately 90% of elimination; less than 1% excreted unchanged; minimal fecal excretion (< 5%).
Category C
Category D/X
Benzodiazepine
Benzodiazepine
"The metabolism of Erythromycin can be decreased when combined with Clobazam."